Cargando…

Clinical and Para Clinical Findings in the Children with Tyrosinemia Referring for Liver Transplantation

BACKGROUND: Hereditary tyrosinemia type 1 (HT1) is a rare autosomal recessive inborn error of metabolism caused by deficiency of fumarylacetoacetate hydrolase enzyme. This disease manifests with severe liver and kidney impairment and is associated with an increased risk of liver cancer. The aim of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehghani, Seyed Mohsen, Haghighat, Mahmood, Imanieh, Mohammad Hadi, Karamnejad, Hossein, Malekpour, Abdorrasoul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898443/
https://www.ncbi.nlm.nih.gov/pubmed/24498493
_version_ 1782300425027846144
author Dehghani, Seyed Mohsen
Haghighat, Mahmood
Imanieh, Mohammad Hadi
Karamnejad, Hossein
Malekpour, Abdorrasoul
author_facet Dehghani, Seyed Mohsen
Haghighat, Mahmood
Imanieh, Mohammad Hadi
Karamnejad, Hossein
Malekpour, Abdorrasoul
author_sort Dehghani, Seyed Mohsen
collection PubMed
description BACKGROUND: Hereditary tyrosinemia type 1 (HT1) is a rare autosomal recessive inborn error of metabolism caused by deficiency of fumarylacetoacetate hydrolase enzyme. This disease manifests with severe liver and kidney impairment and is associated with an increased risk of liver cancer. The aim of this study was to evaluate clinical, laboratory, imaging, and histopathologic characteristics in the children with HT1 who had referred for liver transplantation. METHODS: The present retrospective study was conducted on 45 children with HT1 who had referred to Organ Transplantation Center affiliated to Shiraz University of Medical Sciences between March 2005 and March 2010. RESULTS: There were 64.4% boys and 35.6% girls with mean age of 3.75±1.28 year (ranges from 2 months to 13 years). The most first clinical presentation was hepatic (80%) and the most prevalent physical findings were hepatomegaly (57.8%), splenomegaly (51.1%), ascites (42.2%), and jaundice (37.9%). The most relevant laboratory parameters were the high serum succinylacetone, alpha-fetoprotein, and tyrosine levels. The most common findings in the patient's abdominal ultrasonography were multiple hepatic nodules (75.6%) and inhomogeneous parenchymal echogenicity of liver (48.9%), while hyper and hypo attenuated nodules (60%) and non-homogeneous pattern of liver parenchyma (53.3%) were the most prevalent findings in abdominal computed tomography scan. In the histopathology of the liver, the most important finding was cirrhosis in all the patients. In this study, 14 patients (31.1%) received Nitisinone (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyklohexanedione; NTBC). CONCLUSIONS: This study described clinical and laboratory findings in the children with HT1 who had referred for liver transplantation because of end-stage liver disease from all over country, which indicates delay in diagnosis and treatment of this disease. Considering the results of this study, newborn screening for this disease is highly suggested.
format Online
Article
Text
id pubmed-3898443
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-38984432014-02-04 Clinical and Para Clinical Findings in the Children with Tyrosinemia Referring for Liver Transplantation Dehghani, Seyed Mohsen Haghighat, Mahmood Imanieh, Mohammad Hadi Karamnejad, Hossein Malekpour, Abdorrasoul Int J Prev Med Original Article BACKGROUND: Hereditary tyrosinemia type 1 (HT1) is a rare autosomal recessive inborn error of metabolism caused by deficiency of fumarylacetoacetate hydrolase enzyme. This disease manifests with severe liver and kidney impairment and is associated with an increased risk of liver cancer. The aim of this study was to evaluate clinical, laboratory, imaging, and histopathologic characteristics in the children with HT1 who had referred for liver transplantation. METHODS: The present retrospective study was conducted on 45 children with HT1 who had referred to Organ Transplantation Center affiliated to Shiraz University of Medical Sciences between March 2005 and March 2010. RESULTS: There were 64.4% boys and 35.6% girls with mean age of 3.75±1.28 year (ranges from 2 months to 13 years). The most first clinical presentation was hepatic (80%) and the most prevalent physical findings were hepatomegaly (57.8%), splenomegaly (51.1%), ascites (42.2%), and jaundice (37.9%). The most relevant laboratory parameters were the high serum succinylacetone, alpha-fetoprotein, and tyrosine levels. The most common findings in the patient's abdominal ultrasonography were multiple hepatic nodules (75.6%) and inhomogeneous parenchymal echogenicity of liver (48.9%), while hyper and hypo attenuated nodules (60%) and non-homogeneous pattern of liver parenchyma (53.3%) were the most prevalent findings in abdominal computed tomography scan. In the histopathology of the liver, the most important finding was cirrhosis in all the patients. In this study, 14 patients (31.1%) received Nitisinone (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyklohexanedione; NTBC). CONCLUSIONS: This study described clinical and laboratory findings in the children with HT1 who had referred for liver transplantation because of end-stage liver disease from all over country, which indicates delay in diagnosis and treatment of this disease. Considering the results of this study, newborn screening for this disease is highly suggested. Medknow Publications & Media Pvt Ltd 2013-12 /pmc/articles/PMC3898443/ /pubmed/24498493 Text en Copyright: © International Journal of Preventive Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Dehghani, Seyed Mohsen
Haghighat, Mahmood
Imanieh, Mohammad Hadi
Karamnejad, Hossein
Malekpour, Abdorrasoul
Clinical and Para Clinical Findings in the Children with Tyrosinemia Referring for Liver Transplantation
title Clinical and Para Clinical Findings in the Children with Tyrosinemia Referring for Liver Transplantation
title_full Clinical and Para Clinical Findings in the Children with Tyrosinemia Referring for Liver Transplantation
title_fullStr Clinical and Para Clinical Findings in the Children with Tyrosinemia Referring for Liver Transplantation
title_full_unstemmed Clinical and Para Clinical Findings in the Children with Tyrosinemia Referring for Liver Transplantation
title_short Clinical and Para Clinical Findings in the Children with Tyrosinemia Referring for Liver Transplantation
title_sort clinical and para clinical findings in the children with tyrosinemia referring for liver transplantation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898443/
https://www.ncbi.nlm.nih.gov/pubmed/24498493
work_keys_str_mv AT dehghaniseyedmohsen clinicalandparaclinicalfindingsinthechildrenwithtyrosinemiareferringforlivertransplantation
AT haghighatmahmood clinicalandparaclinicalfindingsinthechildrenwithtyrosinemiareferringforlivertransplantation
AT imaniehmohammadhadi clinicalandparaclinicalfindingsinthechildrenwithtyrosinemiareferringforlivertransplantation
AT karamnejadhossein clinicalandparaclinicalfindingsinthechildrenwithtyrosinemiareferringforlivertransplantation
AT malekpourabdorrasoul clinicalandparaclinicalfindingsinthechildrenwithtyrosinemiareferringforlivertransplantation